Median Technologies (XPAR:ALMDT) Days Payable: 0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALMDT Median Technologies XPAR:ALMDT
49 GF Score
Price €4.11
GF Value €1.73
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Median Technologies Days Payable?

Median Technologies XPAR:ALMDT -3.75% 49 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates XPAR:ALMDT with a GF Score™ of 49/100 and a GF Value™ of €1.73 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Median Technologies ranks worse than 125786.04% on this metric.

Median Technologies's average Accounts Payable for the six months ended in Dec. 2025 was €3.27 Mil. Median Technologies's Cost of Goods Sold for the six months ended in Dec. 2025 was €-0.39 Mil.

The historical rank and industry rank for Median Technologies's Days Payable or its related term are showing as below:

During the past 13 years, Median Technologies's highest Days Payable was 8911.30. The lowest was 2656.92. And the median was 4106.50.

XPAR:ALMDT's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 67.87
* Ranked among companies with meaningful Days Payable only.

Median Technologies's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).


Median Technologies Days Payable Historical Data

* Premium members only.

The historical data trend for Median Technologies's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Median Technologies Days Payable Chart

Median Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,911.30 0.00 0.00 0.00 0.00

Median Technologies Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XPAR:ALMDT vs ABT, SYK, MDT: Days Payable Comparison

For the Medical Devices subindustry, Median Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Median Technologies Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Median Technologies's Days Payable distribution charts can be found below:

* The bar in red indicates where Median Technologies's Days Payable falls into.


XPAR:ALMDT
49GF Score
Median Technologies XPAR:ALMDT
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Median Technologies Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Median Technologies's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (3.159 + 3.367) / 2 ) / -0.695*365
=3.263 / -0.695*365
=N/A

Median Technologies's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (3.176 + 3.367) / 2 ) / -0.385*365 / 2
=3.2715 / -0.385*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Median Technologies (XPAR:ALMDT) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Median Technologies and its competitors. Over the past decade, Median Technologies' Days Payable has ranged from 2,656.92 to 8,911.30. According to the industry distribution chart, Median Technologies ranks #999999 out of 795 companies in the Medical Devices & Instruments industry.
Is Median Technologies' Days Payable too high?
Median Technologies' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 2,656.92 to a high of 8,911.30. Based on the distribution chart, Median Technologies ranks #999999 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Median Technologies has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Median Technologies' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Median Technologies ranks #999999 out of 795 companies for Days Payable. This places Median Technologies in the lower half of its industry. The industry median Days Payable is 67.87. Historically, Median Technologies' own Days Payable has ranged from 2,656.92 to 8,911.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Median Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Median Technologies's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Median Technologies stock overvalued right now?
Based on GuruFocus' analysis, Median Technologies (XPAR:ALMDT) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.73, compared to a current price of €4.11 — trading 137.6% above its estimated fair value. The current Days Payable is 0.00. Median Technologies' overall GF Score™ is 49/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Median Technologies (XPAR:ALMDT), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Median Technologies (XPAR:ALMDT) Overvalued in 2026?

Based on GuruFocus' analysis, Median Technologies stock appears to be overvalued. The current stock price of €4.11 is trading 137.6% above its estimated GF Value™ of €1.73. GuruFocus considers Median Technologies to be Significantly Overvalued.

Key valuation signals for XPAR:ALMDT:

  • Days Payable: 0.00
  • GF Value™: €1.73 vs. price of €4.11 (137.6% above fair value)
  • GF Score™: 49/100 with 8 warning signs

No single metric tells the full story. See the XPAR:ALMDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Median Technologies Business Description

Other Exchanges 4ZG:Germany
Address 1800 Route Des Cretes, Les Deux Arcs, Building B, Valbonne, FRA, 06560
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
49GF Score

Get the complete analysis for XPAR:ALMDT

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.11
Price
€1.73
GF Value